Organization | Clinica Virgen Milagrosa

Clinica Virgen Milagrosa Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial

2009

NCT00876317

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Hospital La Milagrosa

Active Ingredients

Drugs in Phase 3 Trials (1)

torcoxia (1 trial)

Drugs in Other Trials (8)

azithromycin (zithromax) (1 trial)

enoxaparin (lovenox) (1 trial)

hydroxychloroquine (plaquenil) (1 trial)

lopinavir (Kaletra) (1 trial)

piperacillin (pipracil) (1 trial)

ritonavir (Norvir) (1 trial)

tazobactam (Zosyn) (1 trial)

tocilizumab (actemra) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Bursitis (Phase 3)

Rheumatic Diseases (Phase 3)

Soft Tissue Injuries (Phase 3)

Tenosynovitis (Phase 3)

Overview

Highest Phase: Phase 3
# of Trials: 2
# of Trial APIs: 9